PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING OF ATORVASTATIN AND RELATED SPECIES AND PREDICTION OF DRUG-DRUG INTERACTIONS IN HUMANS.

被引：0
|
作者：
Morse, B. L. [1 ]
Alberts, J. J. [1 ]
Kolur, A. [1 ]
Posada, M. M. [1 ]
Tham, L. [1 ]
Loghin, C. [1 ]
Hall, S. D. [1 ]
Dickinson, G. L. [1 ]
Hillgren, K. M. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2019年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-077
引用
收藏
页码：S63 / S64
页数：2
相关论文
共 50 条
  • [1] Physiologically-Based Pharmacokinetic Modeling of Macitentan: Prediction of Drug-Drug Interactions
    de Kanter, Ruben
    Sidharta, Patricia N.
    Delahaye, Stphane
    Gnerre, Carmela
    Segrestaa, Jerome
    Buchmann, Stephan
    Kohl, Christopher
    Treiber, Alexander
    [J]. CLINICAL PHARMACOKINETICS, 2016, 55 (03) : 369 - 380
  • [2] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING (PBPK) OF PITAVASTATIN AND ATORVASTATIN TO PREDICT DRUG-DRUG INTERACTIONS (DDIS).
    Duan, P.
    Zhao, P.
    Zhang, L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S16 - S17
  • [3] Physiologically-Based Pharmacokinetic Modeling of Macitentan: Prediction of Drug–Drug Interactions
    Ruben de Kanter
    Patricia N. Sidharta
    Stéphane Delahaye
    Carmela Gnerre
    Jerome Segrestaa
    Stephan Buchmann
    Christopher Kohl
    Alexander Treiber
    [J]. Clinical Pharmacokinetics, 2016, 55 : 369 - 380
  • [4] Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for atorvastatin and its metabolites
    Zhang, Tao
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 77 : 216 - 229
  • [5] Physiologically-Based Pharmacokinetic Modeling to Support the Clinical Management of Drug-Drug Interactions With Bictegravir
    Stader, Felix
    Battegay, Manuel
    Marzolini, Catia
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (05) : 1231 - 1239
  • [6] Ribociclib Drug-Drug Interactions: Clinical Evaluations and Physiologically-Based Pharmacokinetic Modeling to Guide Drug Labeling
    Samant, Tanay S.
    Huth, Felix
    Umehara, Kenichi
    Schiller, Hilmar
    Dhuria, Shyeilla, V
    Elmeliegy, Mohamed
    Miller, Michelle
    Chakraborty, Abhijit
    Heimbach, Tycho
    He, Handan
    Ji, Yan
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (03) : 575 - 585
  • [7] Physiologically-Based Pharmacokinetic Model Development, Validation, and Application for Prediction of Eliglustat Drug-Drug Interactions
    Sahasrabudhe, Siddhee A.
    Cheng, Shen
    Al-Kofahi, Mahmoud
    Jarnes, Jeanine R.
    Weinreb, Neal J.
    Kartha, Reena, V
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (06) : 1254 - 1263
  • [8] Physiologically Based Pharmacokinetic (PBPK) Modeling of Pitavastatin and Atorvastatin to Predict Drug-Drug Interactions (DDIs)
    Duan, Peng
    Zhao, Ping
    Zhang, Lei
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (04) : 689 - 705
  • [9] Physiologically Based Pharmacokinetic (PBPK) Modeling of Pitavastatin and Atorvastatin to Predict Drug-Drug Interactions (DDIs)
    Peng Duan
    Ping Zhao
    Lei Zhang
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 689 - 705
  • [10] APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING IN PREDICTING DRUG-DRUG INTERACTIONS FOR TELMISARTAN IN HUMANS
    Kim, Jeong Ho
    Heo, Hyunjin
    Min, Jee Sun
    Kim, Doyun
    Bae, Soo Hyeon
    Bae, Soo Kyung
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S109 - S110
12345